Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.
- DOI
- 10.1016/s1474-4422(25)00065-1
- Published
- 2025 May
- Container
- The Lancet. Neurology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1474-4422-25-00065-1,
title = {Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.},
author = {Tassorelli C and Jensen RH and Goadsby PJ and Charles AC and Tepper SJ and Snoer AH and Josiassen MK and Linander CB and Ettrup A and Sperling B and Boneva N},
year = {2025},
journal = {The Lancet. Neurology},
doi = {10.1016/s1474-4422(25)00065-1},
url = {https://doi.org/10.1016/s1474-4422(25)00065-1}
}RIS
TY - JOUR TI - Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial. AU - Tassorelli C AU - Jensen RH AU - Goadsby PJ AU - Charles AC AU - Tepper SJ AU - Snoer AH AU - Josiassen MK AU - Linander CB AU - Ettrup A AU - Sperling B AU - Boneva N PY - 2025 JO - The Lancet. Neurology DO - 10.1016/s1474-4422(25)00065-1 UR - https://doi.org/10.1016/s1474-4422(25)00065-1 ER -
APA
C, T., RH, J., PJ, G., AC, C., SJ, T., AH, S., MK, J., CB, L., A, E., B, S., & N, B. (2025). Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial.. The Lancet. Neurology. https://doi.org/10.1016/s1474-4422(25)00065-1
Source records
- pubmed · retrieved 2026-09-26T05:16:30.991Z